about
CD40 in coronary artery disease: a matter of macrophages?The role of platelets in the recruitment of leukocytes during vascular diseaseThe signaling role of CD40 ligand in platelet biology and in platelet component transfusionPlatelets in inflammation and atherogenesisHuman genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathwayBioavailability and molecular activities of anthocyanins as modulators of endothelial functionInhibitory effects of kiwifruit extract on human platelet aggregation and plasma angiotensin-converting enzyme activity.Multifunctional CD40L: pro- and anti-neoplastic activity.Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burstAugmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury.TNF superfamily protein-protein interactions: feasibility of small- molecule modulationRole of inflammation in atrial fibrillation pathophysiology and management.Platelet-neutrophil interactions under thromboinflammatory conditionsPlasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance.Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways.Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice.The association between impaired glucose tolerance and soluble CD40 ligand: a 15-year prospective cohort study.The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.Regulation of platelet activation and thrombus formation by reactive oxygen speciesClinical significance of costimulatory molecules CD40/CD40L and CD134/CD134L in coronary heart disease: A case-control study.CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L.Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons.CD40L controls obesity-associated vascular inflammation, oxidative stress and endothelial dysfunction in mice - translational aspects for man.Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: a randomized controlled trial.Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.Lung Vascular Remodeling, Cardiac Hypertrophy, and Inflammatory Cytokines in SHIVnef-Infected Macaques.Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.The human blood DNA methylome identifies crucial role of β-catenin in the pathogenesis of Kawasaki disease.CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population
P2860
Q26752784-916A0EA9-33C0-4027-AE0C-7D049C92DC33Q26801407-5E8DEF40-DF50-4292-80EA-870EE4E81452Q26863134-D1F9FD82-1789-4FF2-AFCE-3837E708B651Q28085020-95495560-3EE0-4DE3-BF27-D50D0E2DDDC0Q28488150-2DB799D4-4C99-4AAB-9F0C-5BFFF204DB46Q34212864-53B0A2A9-C2A9-4671-BFA2-413479809031Q34384376-90858386-4856-481A-A3C9-2513DAFC690AQ34422566-5614D2A9-C793-4FBF-99FA-E1CC495E4181Q34778615-2A550B93-3AAE-415A-BDE5-432E27AC64A8Q35044810-7AE45DDB-FD62-4F89-AF5D-A656AB16A8CBQ35534271-A9511C37-CD59-4E9E-8803-1F5947154D29Q35688023-3532DC69-C59C-4385-BE61-A3F878149AA0Q35779411-1E275422-CCFA-482B-9B6F-0FA0C6513135Q36104063-88220230-13BD-408D-B096-D6FB578588D2Q36950012-4D7AD4B0-A3E7-4113-8589-05C4FFD506F0Q37093818-D5E5818D-8072-4CB6-9AFC-0DBFC39F35FFQ37116764-C039AA67-BFEB-43B6-9C50-E0921361B009Q40988795-F98A491B-CD14-46A6-815F-B151D0414EEDQ41140041-3108A276-9F2D-4DC2-8023-F399A52C8454Q41183735-EE97B66C-A36C-4168-82BC-C6984A58BDFBQ41390221-5253435D-C160-459B-88CA-40F4C375783CQ43641406-7A506117-4A15-45AA-A284-D404CDD0AB6EQ43836602-B88CF370-81F2-4BC7-99FC-EBF13CA68211Q44545961-53C80D8B-BE44-4DF4-A42C-5F90952EA13DQ46284193-FCC6A207-8D00-4555-9DD4-F89AAC4C23B3Q47097371-F2ADC2D1-4522-47D8-8697-7F3A73DADABAQ47153937-3B297A2A-0A72-4093-9F4B-C21A06311FADQ47277266-38D8F59B-5762-4485-A1DE-01A747523070Q47661976-170EDA24-0B55-4C38-87E2-B3FE590BE141Q55504414-7668A649-06AA-447E-A2CE-B4A5C7189E00Q58914810-8E97EB17-55FA-4BBE-91B3-672E6A34A321
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The CD40-CD40L system in cardiovascular disease.
@en
The CD40-CD40L system in cardiovascular disease.
@nl
type
label
The CD40-CD40L system in cardiovascular disease.
@en
The CD40-CD40L system in cardiovascular disease.
@nl
prefLabel
The CD40-CD40L system in cardiovascular disease.
@en
The CD40-CD40L system in cardiovascular disease.
@nl
P2860
P1433
P1476
The CD40-CD40L system in cardiovascular disease
@en
P2093
Burak Pamukcu
Gregory Y H Lip
P2860
P304
P356
10.3109/07853890.2010.546362
P407
P577
2011-01-18T00:00:00Z